Updated on 28 August 2026
Partnership offer with UL Faculty of Medicine and Life Sciences Department of Pharmaceutical Sciences
Research Manager at University of Latvia
Riga, Latvia
About
The Department of Pharmaceutical Sciences offers high-quality academic experience, combining innovative research with a strong commitment to interdisciplinary collaboration. We contribute to the university’s academic excellence by preparing knowledgeable and skilled professionals in the field of basic medical sciences, with a particular focus on pharmaceuticals.
We're offering deep scientific expertise in research area of Genetic and Epigenetic Biomarkers:
• Discovery and characterization of molecular markers for the prevention, progression, and treatment of human and animal diseases.
• Development of machine learning models for predicting autoimmune and neurodegenerative disease progression.
• Applications in practical genomics for animal and plant breeding, as well as personalized veterinary medicine.
Besides the deep scientific expertise in genetic and epigenetic Biomarkers, the head of department Tenured Professor, Dr. biol. Una Riekstiņa is deeply passionate about advancing research in precision medicine. Her work focuses on:
-
Cell-based therapeutics – Exploring induced pluripotent stem cells for tissue and organ regeneration, as well as investigating the pathogenesis of rare diseases.
-
Personalized medicine – Utilizing organ-on-a-chip technology to screen medicinal substances for tailored treatments.
-
Targeted therapy – Developing therapeutic agents, diagnostic biosensors, and tools using aptamer and nanomaterials technology.
We are always open to collaboration and innovative research opportunities in these fields. Let's connect!
Topic
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-08 Towards Artificial General Intelligence (AGI) for healthcare
Type
- Partner seeks Consortium/Coordinator
Similar opportunities
Project cooperation
VUMF expertise in HORIZON-HLTH-2027-02-TOOL-01-two-stage
- Partner seeks Consortium/Coordinator
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Giedre Kvedaraviciene
Director, Lithuanian population & rare disorders biobank, Vilnius University Faculty of Medicine at Vilnius University
Vilnius, Lithuania
Project cooperation
NCDs, AI-Driven Predictive Biomarkers and Personalised Medicine Expertise seeking European Partners
- Digital health and AI: HORIZON-HLTH-2027-03-TOOL-04 Virtual Human Twins (VHTs) for integrated clinical decision support in prevention and diagnosis
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Laetitia Gabernet
European Research & Innovation Grant Officer at Mission Europe pour la Recherche
Marseille, France
Project cooperation
- Partner seeks Consortium/Coordinator
- Clinical trials: HORIZON-HLTH-2027-02-DISEASE-01-two-stage Innovative healthcare interventions for non-communicable diseases
- Digital health and AI: HORIZON-HLTH-2027-02-TOOL-01-two-stage Development of predictive biomarkers of disease progression and treatment response by using AI methodologies for chronic non-communicable diseases
Roksana Zakharyan
Senior Researcher, Institute of Molecular Biology at Institute of Molecular Biology
Yerevan, Armenia